Clinical Trial Update: Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports on the safety and tolerability of E5555 in subjects with coronary artery disease, and its effects on markers of intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• E5555

Snippet

Sponsor: Eisai Inc. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED